vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and Neptune Insurance Holdings Inc. (NP). Click either name above to swap in a different company.

CODEXIS, INC. is the larger business by last-quarter revenue ($38.9M vs $37.8M, roughly 1.0× Neptune Insurance Holdings Inc.). CODEXIS, INC. runs the higher net margin — 24.7% vs 0.1%, a 24.5% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs 28.8%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

Neptune Insurance Holdings Inc. is a specialty insurance holding company that offers a broad portfolio of property and casualty insurance products, with a core focus on residential and commercial flood insurance for customers across the United States. It serves both individual consumers and small to mid-sized business clients, using advanced data analytics to support accurate policy pricing and robust risk management.

CDXS vs NP — Head-to-Head

Bigger by revenue
CDXS
CDXS
1.0× larger
CDXS
$38.9M
$37.8M
NP
Growing faster (revenue YoY)
CDXS
CDXS
+52.6% gap
CDXS
81.3%
28.8%
NP
Higher net margin
CDXS
CDXS
24.5% more per $
CDXS
24.7%
0.1%
NP

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CDXS
CDXS
NP
NP
Revenue
$38.9M
$37.8M
Net Profit
$9.6M
$50.0K
Gross Margin
94.8%
Operating Margin
27.1%
Net Margin
24.7%
0.1%
Revenue YoY
81.3%
28.8%
Net Profit YoY
192.5%
0.0%
EPS (diluted)
$0.13
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
NP
NP
Q1 26
$37.8M
Q4 25
$38.9M
Q3 25
$8.6M
$44.4M
Q2 25
$15.3M
Q1 25
$7.5M
Q4 24
$21.5M
Q3 24
$12.8M
$33.8M
Q2 24
$8.0M
Net Profit
CDXS
CDXS
NP
NP
Q1 26
$50.0K
Q4 25
$9.6M
Q3 25
$-19.6M
$11.5M
Q2 25
$-13.3M
Q1 25
$-20.7M
Q4 24
$-10.4M
Q3 24
$-20.6M
$12.1M
Q2 24
$-22.8M
Gross Margin
CDXS
CDXS
NP
NP
Q1 26
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Operating Margin
CDXS
CDXS
NP
NP
Q1 26
Q4 25
27.1%
Q3 25
-220.3%
46.7%
Q2 25
-83.9%
Q1 25
-271.6%
Q4 24
-34.2%
Q3 24
-129.0%
58.6%
Q2 24
-284.9%
Net Margin
CDXS
CDXS
NP
NP
Q1 26
0.1%
Q4 25
24.7%
Q3 25
-228.1%
25.9%
Q2 25
-86.6%
Q1 25
-274.3%
Q4 24
-48.4%
Q3 24
-160.8%
35.8%
Q2 24
-285.2%
EPS (diluted)
CDXS
CDXS
NP
NP
Q1 26
$0.05
Q4 25
$0.13
Q3 25
$-0.22
$0.06
Q2 25
$-0.16
Q1 25
$-0.25
Q4 24
$-0.12
Q3 24
$-0.29
$0.06
Q2 24
$-0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
NP
NP
Cash + ST InvestmentsLiquidity on hand
$78.2M
Total DebtLower is stronger
$40.1M
Stockholders' EquityBook value
$50.5M
Total Assets
$147.8M
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
NP
NP
Q1 26
Q4 25
$78.2M
Q3 25
$58.7M
$12.2M
Q2 25
$66.3M
Q1 25
$59.8M
Q4 24
$73.5M
Q3 24
$90.3M
Q2 24
$73.2M
Total Debt
CDXS
CDXS
NP
NP
Q1 26
Q4 25
$40.1M
Q3 25
$39.7M
$247.6M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
Q3 24
$28.6M
Q2 24
$28.4M
Stockholders' Equity
CDXS
CDXS
NP
NP
Q1 26
Q4 25
$50.5M
Q3 25
$38.5M
$-509.5M
Q2 25
$55.6M
Q1 25
$49.6M
Q4 24
$66.9M
Q3 24
$73.4M
$-374.3M
Q2 24
$61.4M
Total Assets
CDXS
CDXS
NP
NP
Q1 26
Q4 25
$147.8M
Q3 25
$124.0M
$89.6M
Q2 25
$138.2M
Q1 25
$128.9M
Q4 24
$149.0M
Q3 24
$148.2M
Q2 24
$132.0M
Debt / Equity
CDXS
CDXS
NP
NP
Q1 26
Q4 25
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
Q2 24
0.46×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
NP
NP
Operating Cash FlowLast quarter
$20.1M
Free Cash FlowOCF − Capex
$19.6M
FCF MarginFCF / Revenue
50.3%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
2.09×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
NP
NP
Q1 26
Q4 25
$20.1M
Q3 25
$-7.7M
$38.9M
Q2 25
$-18.0M
Q1 25
$-13.8M
Q4 24
$-16.5M
Q3 24
$-13.0M
Q2 24
$-12.2M
Free Cash Flow
CDXS
CDXS
NP
NP
Q1 26
Q4 25
$19.6M
Q3 25
$-7.9M
Q2 25
$-20.5M
Q1 25
$-15.1M
Q4 24
$-18.2M
Q3 24
$-14.0M
Q2 24
$-12.6M
FCF Margin
CDXS
CDXS
NP
NP
Q1 26
Q4 25
50.3%
Q3 25
-91.7%
Q2 25
-133.6%
Q1 25
-199.6%
Q4 24
-85.0%
Q3 24
-109.0%
Q2 24
-157.5%
Capex Intensity
CDXS
CDXS
NP
NP
Q1 26
Q4 25
1.3%
Q3 25
2.1%
Q2 25
16.4%
Q1 25
16.7%
Q4 24
8.3%
Q3 24
7.8%
Q2 24
5.0%
Cash Conversion
CDXS
CDXS
NP
NP
Q1 26
Q4 25
2.09×
Q3 25
3.38×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons